Genpact LTD is 2.9x more valuable than Astrana Health, Inc. by market capitalization ($5.46 B vs $1.88 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | G | ASTH |
|---|---|---|
| Market cap | $5.46 B | $1.88 B |
| US-listed rank | #1323 | #2135 |
| Revenue (latest FY) | $5.08B | $3.18B |
| Net income (latest FY) | $552.49M | $24.00M |
| Net margin | 10.9% | 0.8% |
| P/E (trailing FY) | 9.9 | 78.3 |
| SEC filings | 1,502 | 1,003 |
Genpact LTD is 2.9x more valuable than Astrana Health, Inc. by market capitalization ($5.46 B vs $1.88 B).
In their latest fiscal years, Genpact LTD reported $5.08B in revenue while Astrana Health, Inc. reported $3.18B.
Full pages: Genpact LTD and Astrana Health, Inc., or browse the full rankings.